Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.00
-0.13 (-1.28%)
At close: Jun 8, 2026, 4:00 PM EDT
10.30
+0.30 (3.02%)
After-hours: Jun 8, 2026, 7:02 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $794.3 million as of June 8, 2026. Its market cap has increased by 168.97% in one year.
Market Cap
794.30M
Enterprise Value
1.16B
1-Year Change
168.97%
Ranking
Category
Stock Price
$10.00
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $794.30M, an increase of 50.68%. That is a compound annual growth rate of 6.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 794.30M | -32.70% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 839.80M |
| Arbutus Biopharma | 839.54M |
| Inventiva | 839.46M |
| MeiraGTx Holdings | 833.49M |
| Cullinan Therapeutics | 830.30M |
| LB Pharmaceuticals | 818.14M |
| Janux Therapeutics | 814.75M |
| Replimune Group | 781.96M |